Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hai-Liang Zhu

Showing results (1-10 of 436) with videos related to

Pageof 44
Sort By:
Anti-Cancer Agents in Medicinal Chemistry|April 29, 2011
Resveratrol and its analogues: promising antitumor agentsXianfeng Huang, Hai-Liang Zhu
Anti-Cancer Agents in Medicinal Chemistry|April 28, 2011
Nitroimidazoles as anti-tumor agentsKai Liu, Hai-Liang Zhu
Acta Crystallographica. Section C, Crystal Structure Communications|September 7, 2005
catena-Poly[[[2,4-dichloro-6-(pyridin-2-ylmethyliminomethyl)phenolato]copper(II)]-mu-thiocyanato]Zhong-Lu You, Hai-Liang Zhu
Acta Crystallographica. Section C, Crystal Structure Communications|November 6, 2004
catena-Poly[[di-mu-benzoato-kappa4O:O'-disilver(I)]-mu-N,N'-bis(2-fluorobenzylidene)butane-1,4-diamine-kappa2N:N']Zhong-Lu You, Hai-Liang Zhu
Acta Crystallographica. Section C, Crystal Structure Communications|September 4, 2004
Bis[mu-2-[3-(cyclohexylammonio)propyliminomethyl]phenolato]bis[dichlorocopper(II)]Zhong-Lu You, Hai-Liang Zhu
Expert Opinion on Therapeutic Patents|February 3, 2015
Nitroimidazole derivatives: a patent review of US 2014/0141084 A1Peng-Cheng Lv, Hai-Liang Zhu
Expert Opinion on Therapeutic Patents|March 19, 2011
Targeted antimicrobial moieties (WO2010080819): patent evaluationZhong-Cheng Song, Hai-Liang Zhu
Acta Crystallographica. Section C, Crystal Structure Communications|December 8, 2004
catena-Poly[[(benzoato-kappaO)silver(I)]-mu-2-aminopyrimidine-kappa2N1:N3]Zhong Lu You, Hai Liang Zhu
Expert Opinion on Therapeutic Patents|November 20, 2014
EGFR-binding peptide: a patent evaluation of WO2014002836Peng-Cheng Lv, Hai-Liang Zhu
Acta Crystallographica. Section C, Crystal Structure Communications|August 6, 2005
A novel thiocyanate-bridged dinuclear cadmium(II) complex: di-mu-thiocyanato-bis((methanol){4-nitro-2-[2-(dimethylamino)ethyliminomethyl]phenolato}cadmium(II))Zhong Lu You, Hai Liang Zhu
Pageof 44

Showing results (1-10 of 436) with videos related to

Sort By:
Pageof 44
Anti-Cancer Agents in Medicinal Chemistry|April 29, 2011
Resveratrol and its analogues: promising antitumor agentsXianfeng Huang, Hai-Liang Zhu
Anti-Cancer Agents in Medicinal Chemistry|April 28, 2011
Nitroimidazoles as anti-tumor agentsKai Liu, Hai-Liang Zhu
Acta Crystallographica. Section C, Crystal Structure Communications|September 7, 2005
catena-Poly[[[2,4-dichloro-6-(pyridin-2-ylmethyliminomethyl)phenolato]copper(II)]-mu-thiocyanato]Zhong-Lu You, Hai-Liang Zhu
Acta Crystallographica. Section C, Crystal Structure Communications|November 6, 2004
catena-Poly[[di-mu-benzoato-kappa4O:O'-disilver(I)]-mu-N,N'-bis(2-fluorobenzylidene)butane-1,4-diamine-kappa2N:N']Zhong-Lu You, Hai-Liang Zhu
Acta Crystallographica. Section C, Crystal Structure Communications|September 4, 2004
Bis[mu-2-[3-(cyclohexylammonio)propyliminomethyl]phenolato]bis[dichlorocopper(II)]Zhong-Lu You, Hai-Liang Zhu
Expert Opinion on Therapeutic Patents|February 3, 2015
Nitroimidazole derivatives: a patent review of US 2014/0141084 A1Peng-Cheng Lv, Hai-Liang Zhu
Expert Opinion on Therapeutic Patents|March 19, 2011
Targeted antimicrobial moieties (WO2010080819): patent evaluationZhong-Cheng Song, Hai-Liang Zhu
Acta Crystallographica. Section C, Crystal Structure Communications|December 8, 2004
catena-Poly[[(benzoato-kappaO)silver(I)]-mu-2-aminopyrimidine-kappa2N1:N3]Zhong Lu You, Hai Liang Zhu
Expert Opinion on Therapeutic Patents|November 20, 2014
EGFR-binding peptide: a patent evaluation of WO2014002836Peng-Cheng Lv, Hai-Liang Zhu
Acta Crystallographica. Section C, Crystal Structure Communications|August 6, 2005
A novel thiocyanate-bridged dinuclear cadmium(II) complex: di-mu-thiocyanato-bis((methanol){4-nitro-2-[2-(dimethylamino)ethyliminomethyl]phenolato}cadmium(II))Zhong Lu You, Hai Liang Zhu
Pageof 44